Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00543764 · ClinicalTrials.gov registry record

Intraoperative Pathway in DIEP Flap Breast Reconstruction

A clinical trial of Breast Cancer, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
150
Enrollment target
1
Study location

NCT00543764 is a study of Breast Cancer that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 150 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00543764, a study of Breast Cancer, has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
150 participants
Enrollment target
1
Study location

Study Summary

Efficiency in the operating room can be difficult in long cases with multiple surgeons. We used a team based approach to develop an intraoperative pathway for microsurgical breast reconstruction with a deep inferior epigastric perforator flap.

Conditions Studied

Interventions

  • OTHER pathway

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2005-01
Est. Completion 2011-02

What the Registry Record Tells You About NCT00543764

The ClinicalTrials.gov registry entry for NCT00543764 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which pathway is the first listed.

NCT00543764 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00543764 about?

NCT00543764 is a clinical study titled "Intraoperative Pathway in DIEP Flap Breast Reconstruction". Efficiency in the operating room can be difficult in long cases with multiple surgeons. We used a team based approach to develop an intraoperative pathway for microsurgical breast reconstruction with a deep inferior epigastric perforator flap.

What is the current status of trial NCT00543764?

This trial is currently completed. The enrollment target is 150 participants. The study started on 2005-01. Estimated completion is 2011-02.

What conditions does trial NCT00543764 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT00543764?

The interventions under investigation include: pathway (OTHER).

Who is sponsoring clinical trial NCT00543764?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00543764 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.